Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging

Pharmaceutical Research

Volumn 31, Issue 6, 2014, Pages 1418-1425

  Sun, In Cheol ^a   Na, Jin Hee ^b   Jeong, Seo Young ^b   Kim, Dong Eog ^c   Kwon, Ick Chan ^a,d   Choi, Kuiwon ^a   Ahn, Cheol Hee ^e   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

^c Dongguk University   (South Korea)

^d Korea University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

CT contrast agent; glycol chitosan; gold nanoparticle; tumor targeting

Indexed keywords

CHITOSAN DERIVATIVE; GLYCOL CHITOSAN; GOLD NANOPARTICLE; HEPARIN; POLYMER; UNCLASSIFIED DRUG; BIOMATERIAL; CHITOSAN; CONTRAST MEDIUM; GLYCOL-CHITOSAN; GOLD; METAL NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CHEMICAL MODIFICATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG COATING; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; TISSUE DISTRIBUTION; TUMOR MODEL; TUMOR XENOGRAFT; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; LIVER TUMOR; NEOPLASMS; PATHOLOGY; RADIOGRAPHY; SECONDARY; TOXICITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CHITOSAN; CONTRAST MEDIA; GOLD; HUMANS; LIVER NEOPLASMS; METAL NANOPARTICLES; MICE; NEOPLASMS; TISSUE DISTRIBUTION;

EID: 84902205615     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1142-0     Document Type: Article

References (34)

1. Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104(1):293-346.
2. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res. 2008;41(12):1721-30.
3. Lee S, Cha EJ, Park K, Lee SY, Hong JK, Sun IC, et al. A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew Chem Int Ed. 2008;47(15):2804-7.
4. Mu CJ, LaVan DA, Langer RS, Zetter BR. Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. Acs Nano. 2010;4(3):1511-20.
5. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169-83.
6. Ganesh T. Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem. 2007;15(11):3597-623.
7. Haba Y, Kojima C, Harada A, Ura T, Horinaka H, Kono K. Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability. Langmuir. 2007;23(10):5243-6.
8. Pitsillides CM, Joe EK, Wei XB, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J. 2003;84(6):4023-32.
9. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J Am Chem Soc. 2007;129(24):7661-5.
10. Sun IC, Eun DK, Na JH, Lee S, Kim IJ, Youn IC, et al. Heparin-coated gold nanoparticles for liver-specific CT imaging. Chem Eur J. 2009;15(48):13341-7.
11. Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24(8):1415-26.
12. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12):1912-9.
13. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-8.
14. Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol. 2010;5(6):465-72.
15. Zhang GD, Yang Z, Lu W, Zhang R, Huang Q, Tian M, et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials. 2009;30(10):1928-36.
16. Desai KGH, Park HJ. Preparation and characterization of drug-loaded chitosan-tripolyphosphate microspheres by spray drying. Drug Dev Res. 2005;64(2):114-28.
17. Zhang Y, Zhang MQ. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res. 2002;62(3):378-86.
18. Na JH, Lee SY, Lee S, Koo H, Min KH, Jeong SY, et al. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. J Control Release: Off J Controlled Release Soc. 2012;163(1):2-9.
19. Huh MS, Lee SY, Park S, Lee S, Chung H, Lee S, et al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J Control Release: Off J Controlled Release Soc. 2010;144(2):134-43.
20. Kim JH, Kim YS, Park K, Kang E, Lee S, Nam HY, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials. 2008;29(12):1920-30.
21. Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, et al. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J Control Release: Off J Controlled Release Soc. 2011;152(1):21-9.
22. Na JH, Koo H, Lee S, Min KH, Park K, Yoo H, et al. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials. 2011;32(22):5252-61.
23. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79(939):248-53.
24. Krause W. Liver-specific X-ray contrast agents. Top Curr Chem Contrast Agents II. 2002;222:173-200.
25. Sun IC, Eun DK, Koo H, Ko CY, Kim HS, Yi DK, et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Ed. 2011;50(40):9348-51.
26. Underwood S, Mulvaney P. Effect of the solution refractive-index on the color of gold colloids. Langmuir. 1994;10(10):3427-30.
27. Norman TJ, Grant CD, Magana D, Zhang JZ, Liu J, Cao DL, et al. Near infrared optical absorption of gold nanoparticle aggregates. J Phys Chem B. 2002;106(28):7005-12.
28. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47(1):83-97.
29. Wang XH, Ma JB, Wang YN, He BL. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials. 2001;22(16):2247-55.
30. Crayton SH, Tsourkas A. pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments. Acs Nano. 2011;5(12):9592-601.
31. Hiebert L. The uptake of heparin by liver sinusoidal cells in normal and atherosclerotic rabbits. Thromb Res. 1981;21(4-5):383-90.
32. Frieboes HB, Wu M, Lowengrub J, Decuzzi P, Cristini V. A computational model for predicting nanoparticle accumulation in tumor vasculature. PLoS ONE. 2013;8(2):e56876. doi: 10.1371/journal.pone.0056876.
33. Pearson HJ, Anderson J, Chamberlain J, Bell PRF. The effect of kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunol Immunother. 1986;23(3):214-6.
34. Malter M, Friedrich E, Suss R. Liver as a tumor-cell killing organ - kupffer cells and natural killers. Cancer Res. 1986;46(6):3055-60.